These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 17985932

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. C-terminal domain of insulin-like growth factor (IGF) binding protein 6: conformational exchange and its correlation with IGF-II binding.
    Yao S, Headey SJ, Keizer DW, Bach LA, Norton RS.
    Biochemistry; 2004 Sep 07; 43(35):11187-95. PubMed ID: 15366928
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Interaction of insulin-like growth factor (IGF)-I and -II with IGF binding protein-2: mapping the binding surfaces by nuclear magnetic resonance.
    Carrick FE, Hinds MG, McNeil KA, Wallace JC, Forbes BE, Norton RS.
    J Mol Endocrinol; 2005 Jun 07; 34(3):685-98. PubMed ID: 15956340
    [Abstract] [Full Text] [Related]

  • 5. Contributions of the N- and C-terminal domains of IGF binding protein-6 to IGF binding.
    Headey SJ, Leeding KS, Norton RS, Bach LA.
    J Mol Endocrinol; 2004 Oct 07; 33(2):377-86. PubMed ID: 15525596
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Synthesis and characterization of biotinylated forms of insulin-like growth factor-1: topographical evaluation of the IGF-1/IGFBP-2 AND IGFBP-3 interface.
    Robinson SA, Rosenzweig SA.
    Biochemistry; 2004 Sep 14; 43(36):11533-45. PubMed ID: 15350139
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [The structural organization of binding determinants in insulin-like growth factor-I (IGF-I) molecule].
    Kolychev AP.
    Zh Evol Biokhim Fiziol; 2010 Sep 14; 46(1):74-94. PubMed ID: 20297673
    [Abstract] [Full Text] [Related]

  • 11. Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteins.
    Sitar T, Popowicz GM, Siwanowicz I, Huber R, Holak TA.
    Proc Natl Acad Sci U S A; 2006 Aug 29; 103(35):13028-33. PubMed ID: 16924115
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Perlustrin, a Haliotis laevigata (abalone) nacre protein, is homologous to the insulin-like growth factor binding protein N-terminal module of vertebrates.
    Weiss IM, Göhring W, Fritz M, Mann K.
    Biochem Biophys Res Commun; 2001 Jul 13; 285(2):244-9. PubMed ID: 11444832
    [Abstract] [Full Text] [Related]

  • 17. Insulin-like growth factor-I (IGF-I): solution properties and NMR chemical shift assignments near physiological pH.
    Kuang Z, Yao S, McNeil KA, Forbes BE, Wallace JC, Norton RS.
    Growth Horm IGF Res; 2009 Jun 13; 19(3):226-31. PubMed ID: 19056307
    [Abstract] [Full Text] [Related]

  • 18. The heparin binding domain of insulin-like growth factor binding protein (IGFBP)-3 increases susceptibility of IGFBP-3 to proteolysis.
    Durham SK, Suwanichkul A, Hayes JD, Herington AC, Powell DR, Campbell PG.
    Horm Metab Res; 1999 Jun 13; 31(2-3):216-25. PubMed ID: 10226805
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Molecular recognition characteristics in the insulin-like growth factor (IGF)-insulin-like growth factor binding protein -3/5 (IGFBP-3/5) heparin axis.
    Beattie J, Phillips K, Shand JH, Szymanowska M, Flint DJ, Allan GJ.
    J Mol Endocrinol; 2005 Feb 13; 34(1):163-75. PubMed ID: 15691886
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.